| Id |
Subject |
Object |
Predicate |
Lexical cue |
db_id |
| 3267 |
0-13 |
ChemicalEntity |
denotes |
Antipsychotic |
MESH:D014150 |
| 3268 |
30-42 |
ChemicalEntity |
denotes |
thioperamide |
MESH:C052075 |
| 3269 |
56-67 |
GeneOrGeneProduct |
denotes |
H3-receptor |
NCBIGene:99296 |
| 3270 |
82-86 |
OrganismTaxon |
denotes |
mice |
NCBITaxon:10090 |
| 3271 |
195-208 |
DiseaseOrPhenotypicFeature |
denotes |
schizophrenia |
MESH:D012559 |
| 3272 |
264-287 |
GeneOrGeneProduct |
denotes |
histamine H(3)-receptor |
NCBIGene:99296 |
| 3273 |
299-310 |
ChemicalEntity |
denotes |
neuroleptic |
MESH:D014150 |
| 3274 |
319-328 |
DiseaseOrPhenotypicFeature |
denotes |
catalepsy |
MESH:D002375 |
| 3275 |
330-341 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 3276 |
372-383 |
ChemicalEntity |
denotes |
amphetamine |
MESH:D000661 |
| 3277 |
416-420 |
OrganismTaxon |
denotes |
mice |
NCBITaxon:10090 |
| 3278 |
422-431 |
DiseaseOrPhenotypicFeature |
denotes |
Catalepsy |
MESH:D002375 |
| 3279 |
447-458 |
ChemicalEntity |
denotes |
haloperidol |
MESH:D006220 |
| 3280 |
481-492 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 3281 |
514-525 |
ChemicalEntity |
denotes |
amphetamine |
MESH:D000661 |
| 3282 |
622-647 |
ChemicalEntity |
denotes |
(R)-alpha-methylhistamine |
MESH:C069357 |
| 3283 |
649-653 |
ChemicalEntity |
denotes |
RAMH |
MESH:C069357 |
| 3284 |
677-689 |
ChemicalEntity |
denotes |
thioperamide |
MESH:C052075 |
| 3285 |
691-694 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3286 |
734-743 |
DiseaseOrPhenotypicFeature |
denotes |
catalepsy |
MESH:D002375 |
| 3287 |
763-766 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3288 |
810-821 |
ChemicalEntity |
denotes |
haloperidol |
MESH:D006220 |
| 3289 |
867-876 |
DiseaseOrPhenotypicFeature |
denotes |
catalepsy |
MESH:D002375 |
| 3290 |
922-926 |
ChemicalEntity |
denotes |
RAMH |
MESH:C069357 |
| 3291 |
968-971 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3292 |
989-993 |
ChemicalEntity |
denotes |
RAMH |
MESH:C069357 |
| 3293 |
1089-1092 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3294 |
1154-1165 |
ChemicalEntity |
denotes |
amphetamine |
MESH:D000661 |
| 3295 |
1174-1187 |
DiseaseOrPhenotypicFeature |
denotes |
hyperactivity |
MESH:D006948 |
| 3296 |
1189-1192 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3297 |
1309-1313 |
ChemicalEntity |
denotes |
RAMH |
MESH:C069357 |
| 3298 |
1372-1375 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3299 |
1424-1435 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 3300 |
1472-1475 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3301 |
1530-1534 |
ChemicalEntity |
denotes |
RAMH |
MESH:C069357 |
| 3302 |
1536-1539 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3303 |
1553-1566 |
ChemicalEntity |
denotes |
antipsychotic |
MESH:D014150 |
| 3304 |
1596-1607 |
ChemicalEntity |
denotes |
haloperidol |
MESH:D006220 |
| 3305 |
1616-1625 |
DiseaseOrPhenotypicFeature |
denotes |
catalepsy |
MESH:D002375 |
| 3306 |
1636-1647 |
ChemicalEntity |
denotes |
amphetamine |
MESH:D000661 |
| 3307 |
1656-1669 |
DiseaseOrPhenotypicFeature |
denotes |
hyperactivity |
MESH:D006948 |
| 3308 |
1683-1694 |
ChemicalEntity |
denotes |
apomorphine |
MESH:D001058 |
| 3309 |
1715-1719 |
OrganismTaxon |
denotes |
mice |
NCBITaxon:10090 |
| 3310 |
1737-1740 |
ChemicalEntity |
denotes |
THP |
MESH:C052075 |
| 3311 |
1758-1762 |
ChemicalEntity |
denotes |
RAMH |
MESH:C069357 |
| 3312 |
1793-1817 |
GeneOrGeneProduct |
denotes |
histamine H(3)-receptors |
NCBIGene:99296 |
| 3313 |
1852-1877 |
ChemicalEntity |
denotes |
H(3)-receptor antagonists |
MESH:D054828 |
| 3314 |
1915-1928 |
DiseaseOrPhenotypicFeature |
denotes |
schizophrenia |
MESH:D012559 |
